Showing results (751-760 of 1,074) with videos related to

Sort By:
Pageof 108
Therapeutic Advances in Neurological Disorders|April 30, 2025
Cost-effectiveness of ofatumumab for the treatment of relapsing forms of multiple sclerosis in the United Arab EmiratesJihad Inshasi, Yomna Nowier, Evelina A Zimovetz, et al.
Therapeutic Advances in Neurological Disorders|March 16, 2026
Testing for neural antibodies in autoimmune encephalitis: who, what, where, when, why, and howShaza Almweisheer, Kamala Sangam, Ola Ismail, et al.
Therapeutic Advances in Neurological Disorders|February 23, 2026
Differential response to ofatumumab in anti-AChR and anti-MuSK positive myasthenia gravis patients: a single-center retrospective studyQian Zhou, Yuzhen Ouyang, Fei Jiang, et al.
Therapeutic Advances in Neurological Disorders|February 9, 2024
Prognostic relevance of MRI in early relapsing multiple sclerosis: ready to guide treatment decision making?Olaf Hoffmann, Ralf Gold, Sven G Meuth, et al.
Therapeutic Advances in Neurological Disorders|March 25, 2024
Clinical characteristics and surgical outcomes of low-grade epilepsy-associated brain tumorsSuhui Kuang, Shaohui Zhang, Zhiqiang Cui, et al.
Therapeutic Advances in Neurological Disorders|February 13, 2024
Cytokines (IL1β, IL6, TNFα) and serum cortisol levels may not constitute reliable biomarkers to identify individuals with post-acute sequelae of COVID-19Michael Fleischer, Fabian Szepanowski, Anne K Mausberg, et al.
Therapeutic Advances in Neurological Disorders|July 24, 2023
Complete remission of central nervous system manifestations of IgG4-related disease with rituximab - a case reportAleksi J Sihvonen, Sini M Laakso, Olli Tynninen, et al.
Therapeutic Advances in Neurological Disorders|April 15, 2024
Real-world evidence and patient preference for subcutaneous versus intravenous natalizumab in the treatment of relapsing-remitting multiple sclerosis - initial results from the observational SISTER studyRalf Gold, Stephan Schmidt, Florian Deisenhammer, et al.
Therapeutic Advances in Neurological Disorders|April 18, 2024
A retrospective observational study on characteristics, treatment patterns, and healthcare resource use of patients with myasthenia gravis in EnglandJordy van Enkhuizen, Jean Binns, April Betts, et al.
Therapeutic Advances in Neurological Disorders|April 10, 2024
Development of an algorithm for identifying paraneoplastic ischemic stroke in association with lung, pancreatic, and colorectal cancerRebecca Kassubek, Marc-Andre G R Winter, Jens Dreyhaupt, et al.
Pageof 108